Sponsor
Trump tariff pressure: AstraZeneca to move production to US, announces $50 billion manufacturing push
Posted
AstraZeneca is set to invest $50 billion in the U.S., featuring a large manufacturing plant in Virginia, marking its biggest manufacturing investment. This move aligns with the company's expectation that 50% of its revenue will come from the U.S. by 2030. The decision comes amid rising tariff pressures from the Trump administration, aiming to bolster domestic drug supply chains.
Zoeken
Categorieën
- National
- International
- Business
- Technology
- Health
- Onderwijs
- Sports
- Entertainment
- Travel
- Environment
- Science
- Law
- Agriculture
- Real Estate
- Opinion
- Religion
- Weather
- Automotive
- Social Issues
- Culture
- Sci-Fi & Future
Read More
IND vs ENG | Weather Updates: Rain threat looms over 4th Test in Manchester
The crucial fourth Test between India and England at Old Trafford faces weather uncertainties,...
IND vs ENG: Shastri says Jadeja lacks self-belief – 'If he has even 40%...'
Ravi Shastri believes Ravindra Jadeja needs more self-belief to consistently win matches for...
Three parliamentary committees meeting today
KATHMANDU: Three committees of the Federal Parliament are meeting today to discuss key...
Richa recalls how her Nani warned her about marriage
Richa Chadha recounted a childhood experience where her grandmother's words reflected the gender...
© 2025 Dununu.com : Circle of Life - Santan Social Network
Dutch
